Paediatrics in Berlin

A Barbato1, F Bertuola, C Kuehni

  • 1Department of Paediatric, University of Padova, Padova, Italy.

Insights

This report summarizes key findings from the European Respiratory Society congress, covering asthma, cystic fibrosis, and respiratory infections. It highlights advancements in pediatric intensive care and respiratory physiology, offering insights into current respiratory research.

Area of Science:

  • Pulmonology
  • Allergy and Immunology
  • Pediatric Medicine

Background:

  • The European Respiratory Society (ERS) annual congress is a premier event for disseminating respiratory research.
  • Keeping abreast of the latest advancements across diverse respiratory fields is crucial for clinicians and researchers.

Purpose of the Study:

  • To present a curated overview of significant research highlights from the ERS annual congress.
  • To contextualize key findings within the existing body of respiratory literature.

Main Methods:

  • Selection of top-rated abstracts presented at the ERS congress.
  • Categorization of abstracts into key respiratory domains: asthma, allergy, cystic fibrosis, infections, pediatric/neonatal intensive care, investigative techniques, and epidemiology.
  • Synthesis of presented findings with current scientific literature.

Main Results:

  • Key advancements in asthma and allergy management.
  • Progress in cystic fibrosis treatment strategies.
  • New insights into respiratory infection pathogenesis and treatment.
  • Developments in pediatric and neonatal intensive care.
  • Innovations in pediatric respiratory investigative techniques, including physiology and bronchoscopy.
  • Emerging trends in respiratory epidemiology.

Conclusions:

  • The ERS congress showcased significant progress across major respiratory disciplines.
  • The presented research provides valuable updates for clinical practice and future research directions.
  • Integration of these findings with existing literature enhances understanding of the evolving landscape of respiratory medicine.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...